Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: A histology study
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Summary: Varicose veins are a major chronic venous disease characterised by extensive remodelling of the extracellular matrix architecture in the vascular wall. Although matrix metalloproteinases have been implicated in these pathologic events, little is known about the functional relevance of other protease family members. Here, we studied the distribution of lysosomal cysteine proteases, cathepsins B, L, K, and S, and their endogenous inhibitor, cystatin C, in long saphenous vein specimens from nine normal donors and 18 patients with varicose veins (VVs). Immunohistochemical analysis demonstrated increased levels of cathepsins L, K, B, and S and reduced levels of cystatin C in VVs. This imbalance between cysteinyl cathepsins and cystatin C may favour VV remodelling. To investigate the inflammatory mechanism of their expression, we examined a detailed inflammatory cell profile in VVs, including macrophages, T lymphocytes, and mast cells. Increased numbers of CD3-positive T cells and tryptase-positive mast cells were found in VVs, and enhanced levels of cysteinyl cathepsins were detected from lesion CD3-positive T cells, chymase-positive mast cells, endothelial cells, and smooth-muscle cells. Elevated cathepsins, and their co-localisation to infiltrated inflammatory cells and to vascular cells, suggest that these proteases participate in extracellular matrix degradation in response to inflammation during VV pathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence indicates that cystatin C plays a direct role in various immunological disorders, with its encoding gene being regulated by inflammatory mediators like cytokines in situations of inflammation or infection (16).”
From Investigation of serum cystatin C levels and their diagnostic value in combination with inflammatory ratios in patients with bipolar disorder (2025) · doi:10.3389/fpsyt.2025.1525091 · cites this paper as [16]
Citations
Cites
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,352 · cited 11×
“Inflammatory cell infiltration into the vascular wall is an important feature of VVs, and its central roles are broadly evident in vascular diseases (23-27).”
BackgroundInfluentialLiu, J., Divoux, A., Sun, J., Zhang, J., Clément, K., Glickman, J. N., Sukhova, G. K., Wolters, P. J., Du, J., Gorgun, C. Z., et al. (2009) · Nature Medicine · doi:10.1038/nm.1994 · Cited by 796 · cited 1×
“0 (22), and the data were presented as a ratio of cell marker–positive areas from the tissues.”
BackgroundSelf-citationSukhova, G. K., Shi, G. P., Simon, D. I., Chapman, H. A., & Libby, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci181 · Cited by 665 · cited 2×
“These proteases may mediate SMC migration to the intima and free sufficient space in the media for inflammatory infiltrators, as we have described in human atherosclerotic lesions (39).”
BackgroundResultSelf-citationChanging concepts of atherogenesis
Libby, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00654.x · Cited by 626 · cited 1×
“Normal vascular tissues possess strictly regulated ECM components, whereas focal tissue damage and ECM remodelling occur in vascular disorders, including aortic aneurysm (35), atherosclerosis (36), and VVs (2, 5-10).”
BackgroundCystatin C deficiency in human atherosclerosis and aortic aneurysms
Shi, G.-P., Sukhova, G. K., Grubb, A., Ducharme, A., Rhode, L. H., Lee, R. T., Ridker, P. M., Libby, P., & Chapman, H. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7709 · Cited by 455 · cited 4×
“For example, Cyst C expression is reduced in atheroma (21), abdominal aortic aneurysms (21) and VVs (▶ Figure 3), but its expression remains almost unchanged in balloon-injured carotid arteries (40) and in myocardium of hypertensive heart failure (41).”
BackgroundSelf-citationLysosomal Cysteine Proteases in Atherosclerosis
Liu, J., Sukhova, G. K., Sun, J.-S., Xu, W.-H., Libby, P., & Shi, G.-P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000134530.27208.41 · Cited by 393 · cited 16×
“In AAA and atherosclerosis lesions, various inflam- matory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundResultSelf-citationDeficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Sukhova, G. K., Zhang, Y., Pan, J.-H., Wada, Y., Yamamoto, T., Naito, M., Kodama, T., Tsimikas, S., Witztum, J. L., Lu, M. L., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci14915 · Cited by 372 · cited 4×
“Cathepsin activities in elastin and collagen degradation (16, 17, 42-44), SMC apoptosis (42, 44) and migration (17), angiogenesis (42, 43), macrophage and T-cell transendothelium migration (16, 17, 42, 43), and T-cell proliferation (42-44) from aortic walls may also apply to venous walls - a hypothesis that was not te…”
BackgroundSelf-citationCathepsin cysteine proteases in cardiovascular disease
Lutgens, S. P. M., Cleutjens, K. B. J. M., Daemen, M. J. A. P., & Heeneman, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7924com · Cited by 351 · cited 12×
“In AAA and atherosclerosis lesions, various inflam- matory cells, including monocytes/macrophages, T cells, and MCs, participate in vascular ECM remodelling by releasing inflammatory cytokines to regulate vascular cell cathepsin expression or by directly releasing cathepsins (11, 18, 24).”
BackgroundInfluentialSaarinen, J., Kalkkinen, N., Welgus, H. G., & Kovanen, P. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32427-4 · Cited by 315 · cited 11×
“Therefore, although a counterbalance between MMPs and TIMPs may affect vein structural integrity (5), other families of proteolytic enzymes may also participate in VV development.”
BackgroundInfluentialDeficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient mice
Sukhova, G. K., Zhang, Y., Pan, J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314915 · Cited by 314
Self-citation
Cited by
Vascular wall extracellular matrix proteins and vascular diseases
Xu, J., & Shi, G.-P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.008 · Cited by 381
Self-citationInvolvement of cystatin C in immunity and apoptosis
Zi, M., & Xu, Y. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.006 · Cited by 170
“However, recent studies increasingly reported direct involvement of cystatin C in many immunological disorders other than renal diseases, and cystatin C encoding gene can be subject to the regulation of cytokines under inflammatory or infectious conditions [15,16].”
BackgroundCystatin C is a disease‐associated protein subject to multiple regulation
Xu, Y., Ding, Y., Li, X., & Wu, X. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2014.121 · Cited by 111
“14, 15 Thus, the oscillation of blood Cst C levels could actually reflect the change of Cst C production, consumption, inactivation or fibrillation (mentioned later) rather than its filtration in the kidney, and the readout of plasma Cst C concentration might have different clinical implications.”
BackgroundBarallobre‐Barreiro, J., Öklü, R., Lynch, M., Fava, M., Baig, F., Yin, X., Barwari, T., Potier, D. N., Albadawi, H., Jahangiri, M., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw075 · Cited by 69
“For example, increased levels of cathepsins have been observed in VSV.(39)”
BackgroundDilating venous disease: Pathophysiology and a systematic aspect to different vascular territories
Yetkın, E., & İleri, M. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.04.016 · Cited by 47
Metadata
- Authors
- Xu, N., Zhang, Y.-Y., Lin, Y., Bao, B., Zheng, L., Shi, G.-P., & Liu, J.
- Affiliations
- Hefei University of Technology (CN)
- Brigham and Women's Hospital (US)
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2014
- Volume
- 112
- Issue
- 02
- Pages
- 333-344
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2027617961
- Cited by
- 15
- References
- 56
- Citations by year
- 2025: 3 · 2023: 1 · 2021: 1 · 2020: 3 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation (Grant No. 31171315, to J.L.)
- Topics
- Health Sciences › Medicine › Surgery › Diagnosis and Treatment of Venous Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- varicose veins, cathepsin L, cathepsin K, cathepsin B, cathepsin S, cystatin C, chronic venous disease, extracellular matrix remodeling, matrix degradation, inflammation, mast cells, T cells, macrophages, great saphenous vein, endothelial cells, smooth muscle cells
- MeSH terms
- Adult, Cathepsins, Female, Humans, Immunohistochemistry, Inflammation, Male, Mast Cells, Middle Aged, Muscle, Smooth, Vascular, Saphenous Vein, T-Lymphocytes, Varicose Veins, Biomarkers, Up-Regulation, Case-Control Studies, Myocytes, Smooth Muscle, Endothelial Cells, Cystatin C
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: A histology study. https://app.cochat.ai/papers/10.1160/th13-04-0309
- The paper
- Xu, N., Zhang, Y.-Y., Lin, Y., Bao, B., Zheng, L., Shi, G.-P., & Liu, J. (2014). Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: A histology study. Thrombosis and Haemostasis. https://doi.org/10.1160/th13-04-0309
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.